enVVeno Medical Corp (NVNO) stock
NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.77+0.00 (0.00%)
Close on Nov 18, 2026Market cap $4.01MP/E –Yield –
enVVeno Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
enVVeno Medical's operating income for the twelve months ending Sep 30, 2026 was -$16.41M. For fiscal 2025 it was -$20.90M. The highest annual figure on record is -$6.10M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.90M | – |
| FY2024 | Dec 31, 2024 | -$23.83M | – |
| FY2023 | Dec 31, 2023 | -$25.24M | – |
| FY2022 | Dec 31, 2022 | -$24.93M | – |
| FY2021 | Dec 31, 2021 | -$16.89M | – |
| FY2020 | Dec 31, 2020 | -$9.14M | – |
| FY2019 | Dec 31, 2019 | -$7.68M | – |
| FY2018 | Dec 31, 2018 | -$7.85M | – |
| FY2017 | Dec 31, 2017 | -$6.10M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$4.53M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.01M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.88M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.17M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.45M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.35M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.80M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.99M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.71M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.39M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.16M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.51M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.30M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.83M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.58M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.80M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.11M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.46M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.93M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.81M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.23M | – |
See a number that looks wrong?